US CMS (Centers for Medicare and Medicaid Services) unveils changes to Medicare technology reimbursement process
This article was originally published in Clinica
The US Centers for Medicare and Medicaid Services (CMS) has updated its process for making national coverage decisions. The changes, announced today in a notice published in the Federal Register, implement certain requirements of the Medicare, Medicaid and SCHIP Benefits Improvement and Protection act of 2000 (BIPA) and incorporate lessons learned since the agency launched its open coverage process three years ago.
You may also be interested in...
The UK has approved the mRNA-based vaccine just nine days after receiving the final Phase III results from Pfizer.
As the MHRA prepares to grant approval to the Oxford/AstraZeneca vaccine, Wockhardt is set to supply 100 million doses for the UK government’s own use and its WHO commitments. The company is also in talks with global vaccine developers to manufacture their COVID-19 vaccines for emerging economies
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.